Egypt’s Pharma Chamber seeks fair market – El-Leithy

Egypt’s Pharmaceutical Cosmetics & Medical Supplies Chamber’s Chairman Gamal El-Leithy emphasised on Monday the need to enhance the Egyptian Competition Authority’s (ECA) role in the pharmaceutical sector.

Speaking during the third session of the ECA’s second annual conference, El-Leithy highlighted that safeguarding competition is crucial for protecting investments, according to an official statement.

El-Leithy emphasised the importance of competition law having mechanisms in place to safeguard companies and investors from any practices that could potentially harm the sector.

He emphasised the necessity of coordination between the ECA and other relevant ministries such as the Ministry of Health, the Ministry of Investment, and the Egyptian Drug Authority (EDA).

He stated that the pharmaceutical sector in Egypt encounters distinct pricing challenges, with medicines being the sole products subject to mandatory pricing, resulting in difficulties with the Ministry of Health and the pricing system.

El-Leithy pointed out that ECA should play an active role in guiding companies and investors, clearly outlining the limits of laws and regulations related to competition, the statement added.

Attribution: Amwal Al Ghad English
Subediting: M. S. Salama